Garc´ıa Ruano et al.
7.1 Hz), 3.96 (m, 2H), 3.87 (m, 1H), 3.78 (dd, 1H, J ) 7.2 and 2.0
Hz), 3.69 (m, 1H), 2.43 (s, 3H), 1.99 (s, 3H), 1.71 (s, 3H), 1.30 (t,
3H, J ) 7.2 Hz), 1.25 (t, 3H, J ) 7.1 Hz).
with the corresponding sulfoxide. After 1 min at room temperature,
complete transformation of sulfone was observed by TLC. The
spectroscopic signals corresponding to adducts anti-15′-endo and
syn-15′-endo and those of other two possible adducts were observed
in a ratio of 71:18:7:4 in the 1H NMR spectrum of the crude reaction
mixture. The products anti-15′-endo and syn-15′-endo were isolated
by column chromatography using hexane-ethyl acetate (4:1) as the
eluent.
Ethyl [8S,(S)S]-2-[2-(Acetyloxy)ethyl]-3-methyl-8-menthyloxy-
8a-(phenylsulfinyl)-6-oxo-5a,6,8a,8b-tetrahydro-5H,8H-furo[3′,4′:
3,4]pyrrolo[2,1-b][1,3]thiazole-5-carboxylate (15). To a stirred
solution of (S,S)-4-phenylsulfinylfuranone (7) (0.55 mmol) in dry
acetonitrile (8 mL), under argon at room temperature, was added
quickly a solution of ylide 2 (0.8 mmol) in dry acetonitrile (4 mL),
freshly prepared by addition of TMP (0.8 mmol) to a suspension
of thiazolium salt 2-HBr (0.9 mmol) in dry acetonitrile (4 mL).
After 5 min, dichloromethane was added to the reaction mixture,
and it was washed with water. The aqueous layers were extracted
with dichloromethane several times. The organic layers were dried
(Na2SO4), filtered, and concentrated in vacuo. The 1H NMR
spectrum shows a mixture of diastereoisomers anti-15-endo and
syn-15-endo in 93:7 ratio, along with the starting material 7 and
other compounds. Diastereoisomers 15 were purified by flash
column chromatography (AcOEt-hexane, 1:3).
anti-15′-endo (major): 61% isolated yield; white solid; mp
89-90 °C (recrystallized from diethyl ether-hexane); [R]20D -34.5
(c ) 0.5, CHCl3); IR (neat) 1781, 1737, 1656, 1585, 1449, 1370,
1
1223, 1147 cm-1; H NMR (CDCl3, 300 MHz) δ 7.88 (m, 2H),
7.66 (m, 1H), 7.53 (m, 2H), 6.33 (s, 1H), 6.04 (s, 1H), 4.88 (s,
1H), 4.35 (q, 2H, J ) 7.1 Hz), 4.23 (s, 1H), 4.06 (m, 2H), 3.40 (dt,
1H, J ) 10.8 and 4.3 Hz), 2.54 (m, 1H), 2.42 (m, 1H), 2.16 (m,
1H), 2.03 (s, 3H), 1.72-0.54 (m, 17H), 1.68 (s, 3H), 1.39 (t, 3H,
J ) 7.1 Hz); 13C NMR (CDCl3, 75 MHz) δ 172.9 (C), 170.9 (C),
168.6 (C), 139.0 (C), 134.1 (CH), 133.1 (C); 130.7 (CH), 128.5
(CH), 104.1 (CH), 104.0 (C), 82.3 (CH), 80.8 (CH), 73.6 (CH),
66.2 (CH), 62.8 (CH2), 62.2 (CH2), 50.9 (CH), 48.5 (CH), 42.2
(CH2), 34.0 (CH2), 31.7 (CH), 26.9 (CH2), 24.3 (CH), 22.6 (CH2),
22.0 (CH3), 21.3 (CH3), 20.9 (CH3), 15.8 (CH3), 14.1 (CH3), 11.6
(CH3). Anal. Calcd for C32H43NO9S2: C, 59.15; H, 6.67; N, 2.16;
S, 9.87. Found: C, 59.25; H, 6.69; N, 2.51; S, 9.61.
[5S,5aR,8S,8aR,8bR,(S)S]-anti-15-endo. Compound anti-15-
endo was obtained as the major cycloadduct. It was isolated by
precipitation of a mixture of isomers anti-15-endo and syn-15-endo
(86:14) from AcOEt-hexane: yield 39%; mp (AcOEt-hexane)
102-103 °C; [R]D -50.4 (c 0.5, CHCl3); IR (KBr) 1776, 1754,
1726, 1443, 1383, 1311, 1253, 1121, 1043 cm-1; 1H NMR (CDCl3,
300 MHz) δ 7.83 (m, 2H), 7.53 (m, 3H), 6.04 (s, 1H), 5.97 (s,
1H), 4.55 (d, 1H, J ) 1.7 Hz), 4.29-4.07 (m, 4H), 3.63 (dt, 1H,
J ) 10.8 and 4.1 Hz), 3.53 (d, 1H, J ) 1.7 Hz), 2.66 (m, 1H), 2.45
(m, 2H), 2.14 (m, 2H), 2.06 (s, 3H), 1.76-0.80 (m, 15 H), 1.67 (s,
3H), 1.34 (t, 3H, J ) 7.2 Hz); 13C NMR (CDCl3, 75 MHz) δ 172.8
(C), 170.8 (C), 168.6 (C), 140.9 (C), 133.5 (C); 131.9 (CH), 129.1
(CH), 126.8 (CH), 106.4 (CH), 103.6 (C), 85.0 (CH), 79.4 (C),
71.0 (CH), 65.7 (CH), 62.5 (CH2), 62.4 (CH2), 49.1 (CH), 48.5
(CH), 42.6 (CH2), 34.0 (CH2), 31.5 (CH), 27.2 (CH2), 25.0 (CH),
22.6 (CH2), 22.1 (CH3), 21.2 (CH3), 20.9 (CH3), 16.0 (CH3), 14.2
(CH3), 11.6 (CH3). Anal. Calcd for C32H43NO8S2: C, 60.64; H, 6.84;
N, 2.21; S, 10.12. Found: C, 60.32; H, 6.74; N, 2.19; S, 9.98.
[5R,5aS,8S,8aS,8bS,(S)S]-syn-15-endo. Compound syn-15-endo
was obtained as the minor cycloadduct. It could not be isolated
diastereoisomerically pure. The spectroscopic parameters were
obtained from the spectrum of a 25:75 mixture of anti-15-endo
syn-15′-endo (minor): 16%; 1H NMR (CDCl3, 300 MHz) δ 7.98
(m, 2H), 7.75 (m. 1H), 7.60 (m, 2H), 6.14 (s, 1H), 5.82 (s, 1H),
4.31-4.05 (m, 6H), 3.55 (dt, 1H, J ) 10.6 and 4.4 Hz), 2.67-0.78
(m, 20H), 2.03 (s, 3H), 1.74 (s, 3H), 1.31 (t, 3H, J ) 7.1 Hz); 13
C
NMR (CDCl3, 75 MHz) δ 171.0 (C), 170.8 (C), 170.2 (C), 135.9
(C), 135.1 (CH), 134.9 (C), 130.5 (CH), 129.3 (CH), 119.3 (C),
101.7 (CH), 83.8 (CH), 81.3 (C), 75.5 (CH), 67.3 (CH), 62.9 (CH2),
62.1 (CH2), 52.3 (CH), 47.9 (CH), 41.8 (CH2), 33.9 (CH2), 31.6
(CH), 26.7 (CH2), 24.8 (CH), 22.7 (CH2), 22.1 (CH3), 21.2 (CH3),
1
20.9 (CH3), 16.0 (CH3), 14.0 (CH3), 13.8 (CH3); H NMR (C6D6,
300 MHz) δ 7.93 (m, 2H), 6.91 (m, 3H), 6.33 (s, 1H), 5.99 (s,
1H), 4.54 (d, 1H, J ) 3.4 Hz), 4.29 (d, 1H, J ) 3.4 Hz), 3.86 (m,
2H), 3.48 (dt, 1H, J ) 10.6 and 4.5 Hz), 2.60-0.60 (m, 20H),
1.68 (s, 3H), 1.55 (s, 3H), 0.92 (t, 3H, J ) 7.1); 13C NMR (C6D6,
75 MHz) δ 171.1 (C), 170.5 (C), 170.3 (C), 136.7 (C), 136.3 (C),
135.0 (CH), 131.1 (CH), 129.3 (CH), 121.2 (C), 102.2 (CH), 84.4
(CH), 82.2 (C), 77.1 (CH), 68.3 (CH), 63.0 (CH2), 62.1 (CH2),
53.5 (CH), 48.8 (CH), 42.6 (CH2), 34.5 (CH2), 32.0 (CH), 27.3
(CH2), 25.5 (CH), 23.3 (CH2), 22.6 (CH3), 21.9 (CH3), 20.8 (CH3),
16.7 (CH3), 14.3 (CH3).
1
and syn-15-endo: H NMR (CDCl3, 300 MHz) δ 7.79 (m, 2H),
7.57 (m, 3H), 5.88 (s, 1H), 5.82 (s, 1H), 4.27-4.08 (m, 4H), 4.00
(d, 1H, J ) 3.6 Hz), 3.72 (d, 1H, J ) 3.6 Hz), 3.57 (td, 1H, J )
10.5 and 4.0 Hz), 2.72-0.75 (m, 20H), 2.05 (s, 3H), 1.73 (s, 3H),
1.30 (t, 3H, J ) 7.1 Hz); 13C NMR (CDCl3, 75 MHz) δ 171.9 (C),
170.8 (C), 170.7 (C), 138.2 (C), 136.3 (C), 132.6 (CH), 129.3 (CH),
126.3 (CH), 121.6 (C), 102.2 (CH), 84.1 (CH), 78.0 (C), 76.2 (CH),
67.4 (CH), 63.1 (CH2), 62.0 (CH2), 49.5 (CH), 47.9 (CH), 42.0
(CH2), 34.0 (CH2), 31.6 (CH), 26.8 (CH2), 25.1 (CH), 22.8 (CH2),
22.1 (CH3), 21.1 (CH3), 20.8 (CH3), 16.1 (CH3), 14.0 (CH3), 13.9
(CH3).
Acknowledgment. We thank the Spanish Government
(DGICYT, Grant No. CTQ2006-06741/BQU) and Comunidad
Auto´noma de Madrid (CCG07-UAM/PPQ-1849) for financial
support.
Supporting Information Available: Experimental proce-
dures and spectroscopic data for compounds 2-HBr and 13a1-
13b2, NMR spectra of all new compounds, and crystallographic
data for compound anti-15-endo (CIF). This material is available
Ethyl [8S,(S)S]-2-[2-(Acetyloxy)ethyl]-3-methyl-8-menthyloxy-
8a-(phenylsulfonyl)-6-oxo-5a,6,8a,8b-tetrahydro-5H,8H-furo[3′,4′:
3,4]pyrrolo[2,1-b][1,3]thiazole-5-carboxylates (15′). The com-
pounds were obtained from dipole 2 and [(S)S,5S)]-5-(l)-menthyloxy-
4-phenylsulfonylfuran-2(5H)-one (7′) following the procedure used
JO801705D
8490 J. Org. Chem. Vol. 73, No. 21, 2008